Sunday, December 10, 2023

Recent US policy developments in psychedelics

Recent policy developments and advances in psychedelic research demonstrate a fundamental change in perception and regulation of these substances in the United States: Massachusetts Ballot...

US Veteran’s Administration open to exploring psychedelics to treat PTSD

Since recently, an increasing number of military veterans have turned to psychedelic therapy as an unconventional treatment for post-traumatic stress disorder (PTSD). While this...

Members of European Parliament Advocate EU Support Research into Psychedelic Drugs for Treating Mental Health Disorders

Recently, there has been an surge of advocacy surrounding psychedelic therapies as potential breakthroughs for treating mental health disorders. This movement has now spread...


Cybin Phase 2, Washington and Oregon Policy, Legal Psychedelics, and Reduced Investment Outlook

Cybin's Phase 2 Study Results Cybin, a prominent psychedelic biotech company, has revealed significant findings from its Phase 2 study of CYB003, a psilocybin analogue,...

Get Free Psytelligence!

Sign up to receive awesome content in your inbox, every week.

We don’t spam! Read our privacy policy for more info.